<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".02" citation="COMAR 10.32.20.02" title_num="10" subtitle_num="32" chapter_num="20" heading="Definitions.">
  <paragraph num="A.">
    <text>In this chapter, the following terms have the meanings indicated.</text>
  </paragraph>
  <paragraph num="B.">
    <text>Terms Defined.</text>
    <paragraph num="(1)">
      <text>“Accredited educational program” means a program accredited by The Commission on Accreditation of Allied Health Education Programs (CAAHEP), or its successor accrediting agency.</text>
    </paragraph>
    <paragraph num="(2)">
      <text>“Board” means the State Board of Physicians.</text>
    </paragraph>
    <paragraph num="(3)">
      <text>“Certified clinical perfusionist” means an individual holding a certificate issued by the national certifying board.</text>
    </paragraph>
    <paragraph num="(4)">
      <text>“Certification” means recognition of an individual who has satisfied certain standards required by the national certifying board.</text>
    </paragraph>
    <paragraph num="(5)">
      <text>“Committee” means the Perfusion Advisory Committee established under Health Occupations Article, §14-5E-05, Annotated Code of Maryland.</text>
    </paragraph>
    <paragraph num="(6)">
      <text>“Conversion” means changing a license from licensed perfusionist-basic to licensed perfusionist-advanced.</text>
    </paragraph>
    <paragraph num="(7)">
      <text>“Disciplinary panel” means a panel established under Health Occupations Article, §14-401, Annotated Code of Maryland, which:</text>
      <paragraph num="(a)">
        <text>Is composed of 11 Board members; and</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Addresses:</text>
        <paragraph num="(i)">
          <text>Complaints and disciplinary actions against licensed physicians and allied health professionals;</text>
        </paragraph>
        <paragraph num="(ii)">
          <text>Initial licensure decisions; and</text>
        </paragraph>
        <paragraph num="(iii)">
          <text>Postdisciplinary licensure reinstatements.</text>
        </paragraph>
      </paragraph>
    </paragraph>
    <paragraph num="(8)">
      <text>“Immediately available direction” means the responsibility of a licensed physician to provide necessary direction for a licensed perfusionist in person, by telephone, or by other electronic means.</text>
    </paragraph>
    <paragraph num="(9)">
      <text>“Joint Commission” means the organization formerly known as the Joint Commission on the Accreditation of Health Care Organizations.</text>
    </paragraph>
    <paragraph num="(10)">
      <text>“License” means a license issued by the Board to practice perfusion.</text>
    </paragraph>
    <paragraph num="(11)">
      <text>“Licensed perfusionist” means a perfusionist who is licensed by the Board, in accordance with Health Occupations Article, Title 14, Subtitle 5E, Annotated Code of Maryland, to practice perfusion as a:</text>
      <paragraph num="(a)">
        <text>Licensed perfusionist-advanced; or</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Licensed perfusionist-basic.</text>
      </paragraph>
    </paragraph>
    <paragraph num="(12)">
      <text>“Licensed perfusionist-advanced” means an individual who is licensed by the Board as a perfusionist based on current certification as a certified clinical perfusionist.</text>
    </paragraph>
    <paragraph num="(13)">
      <text>“Licensed perfusionist-basic” means an individual who:</text>
      <paragraph num="(a)">
        <text>Is licensed by the Board as a perfusionist for a limited time based on graduation from an accredited perfusion educational program; and</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Has not yet passed the national certifying examinations given by the national certifying board.</text>
      </paragraph>
    </paragraph>
    <paragraph num="(14)">
      <text>“Licensed physician” means a physician licensed by the Board.</text>
    </paragraph>
    <paragraph num="(15)">
      <text>“National Certifying Board” means the American Board of Cardiovascular Perfusion or its successor.</text>
    </paragraph>
    <paragraph num="(16)">
      <text>“National certifying examinations” means the two examinations given by the national certifying board.</text>
    </paragraph>
    <paragraph num="(17)">
      <text>“On-site direction” means the responsibility of a licensed physician to provide necessary direction for a licensed perfusionist when the physician is:</text>
      <paragraph num="(a)">
        <text>Physically present in the procedure room or in the facility; and</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Able to respond if the perfusionist needs assistance during a procedure.</text>
      </paragraph>
    </paragraph>
    <paragraph num="(18)">
      <text>Practice Perfusion.</text>
      <paragraph num="(a)">
        <text>“Practice perfusion” means to perform the functions necessary for the support, treatment, measurement, or supplementation of the cardiovascular, circulatory, or respiratory systems, or other organs to ensure the safe management of physiologic functions by monitoring and analyzing the parameters of the systems under an order and the supervision of a licensed physician.</text>
      </paragraph>
      <paragraph num="(b)">
        <text>“Practice perfusion” includes:</text>
        <paragraph num="(i)">
          <text>Cardiopulmonary bypass for adult, pediatric, and neonatal patients;</text>
        </paragraph>
        <paragraph num="(ii)">
          <text>Extracorporeal circulatory support for renal, neurological, hepatic, and vascular surgery;</text>
        </paragraph>
        <paragraph num="(iii)">
          <text>Extracorporeal resuscitation;</text>
        </paragraph>
        <paragraph num="(iv)">
          <text>Extracorporeal circulation for long-term support of failing respiratory or cardiac function;</text>
        </paragraph>
        <paragraph num="(v)">
          <text>Extracorporeal membrane oxygenation;</text>
        </paragraph>
        <paragraph num="(vi)">
          <text>Extracorporeal carbon dioxide removal;</text>
        </paragraph>
        <paragraph num="(vii)">
          <text>Myocardial protection;</text>
        </paragraph>
        <paragraph num="(viii)">
          <text>Perfusion-assisted direct coronary artery bypass;</text>
        </paragraph>
        <paragraph num="(ix)">
          <text>Hemofiltration and hemodialysis;</text>
        </paragraph>
        <paragraph num="(x)">
          <text>Anticoagulation and hemostasis monitoring, analysis, and intervention;</text>
        </paragraph>
        <paragraph num="(xi)">
          <text>Thermal regulation;</text>
        </paragraph>
        <paragraph num="(xii)">
          <text>Blood gas and blood chemistry monitoring, analysis, and intervention;</text>
        </paragraph>
        <paragraph num="(xiii)">
          <text>Physiological monitoring, analysis, and intervention;</text>
        </paragraph>
        <paragraph num="(xiv)">
          <text>Administration of blood components and pharmaceuticals;</text>
        </paragraph>
        <paragraph num="(xv)">
          <text>Administration of anesthetic agents through a heart lung machine at the direction of an anesthesiologist;</text>
        </paragraph>
        <paragraph num="(xvi)">
          <text>Ventricular assist device and mechanical circulatory support management;</text>
        </paragraph>
        <paragraph num="(xvii)">
          <text>Intra-aortic balloon counterpulsation;</text>
        </paragraph>
        <paragraph num="(xviii)">
          <text>Temporary pacemaker management;</text>
        </paragraph>
        <paragraph num="(xix)">
          <text>Periodic flow augmentation therapy;</text>
        </paragraph>
        <paragraph num="(xx)">
          <text>Autotransfusion;</text>
        </paragraph>
        <paragraph num="(xxi)">
          <text>Platelet gel production, autologous hemocyte tissue matrix production;</text>
        </paragraph>
        <paragraph num="(xxii)">
          <text>Nondifferentiated progenitor cell harvest bone marrow aspirate concentration;</text>
        </paragraph>
        <paragraph num="(xxiii)">
          <text>Acute normovolemic hemodilution;</text>
        </paragraph>
        <paragraph num="(xxiv)">
          <text>Isolated limb or organ delivery of chemotherapeutics, progenitor cells, gene therapy vectors, and other items;</text>
        </paragraph>
        <paragraph num="(xxv)">
          <text>Organ procurement and preservation;</text>
        </paragraph>
        <paragraph num="(xxvi)">
          <text>Thermogenic lavage;</text>
        </paragraph>
        <paragraph num="(xxvii)">
          <text>Electrophysiological analysis;</text>
        </paragraph>
        <paragraph num="(xxviii)">
          <text>Therapeutic hyperthermia;</text>
        </paragraph>
        <paragraph num="(xxix)">
          <text>Intravascular membrane oxygenation; and</text>
        </paragraph>
        <paragraph num="(xxx)">
          <text>Renal perfusion.</text>
        </paragraph>
      </paragraph>
    </paragraph>
    <paragraph num="(19)">
      <text>“Student” means an individual who, in accordance with Health Occupations Article, §14-5E-09(c), Annotated Code of Maryland, is:</text>
      <paragraph num="(a)">
        <text>Enrolled in an accredited educational program to qualify for a license; and</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Performing perfusion services within the accredited program under the supervision of a licensed perfusionist and without compensation.</text>
      </paragraph>
    </paragraph>
    <paragraph num="(20)">
      <text>“Supervision” means the responsibility of a licensed physician to exercise on-site direction or immediately available direction for a licensed perfusionist to ensure the safety and welfare of patients during the course of perfusion.</text>
    </paragraph>
  </paragraph>
</regulation>